A research team has developed a new class of compounds that effectively inhibit both wild-type CDK9 and its drug-resistant ...

Researchers led by Université de Montréal pathology and cell-biology professor Marc Therrien have identified major structural ...

Biodexa Pharmaceuticals PLC Shareholder Update Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a ...

Bcl6 regulates the lineage stability and suppressive function of Treg cells in head and neck squamous cell carcinoma ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New ...

A study has uncovered a surprising link between diet, intestinal microbes and the efficacy of cancer therapy. A Ludwig Cancer Research study has uncovered a surprising link between diet, intestinal ...

Patients with vitiligo experience impacts on quality of life, emerging therapies offer promising prospects for more targeted ...

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

A 56-year-old man presented for 3 weeks of intermittent blurred vision and photophobia.His medical history included type 2 diabetes, hypertension, hyperlipidemia, chronic obstructive pulmonary disease ...